What does CUSIP 874060205 represent in this 13F holders report?

CUSIP 874060205 is the security identifier for TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS used to aggregate holder disclosures.

How many institutions held TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in Q2 2017?

8 institutional investors reported TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS for Q2 2017. Use the holders table for investor-level position and value details.

TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK)

CUSIP: 874060205

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / SPONSORED ADS
Total 13F shares: 1,039,668
Share change: +130,128
Total reported value: $26,417,135
Price per share: $25.06
Number of holders: 8
Value change: +$3,307,044
Number of buys: 3
Number of sells: 2

Quarterly Holders Quick Answers

What is CUSIP 874060205?
CUSIP 874060205 identifies TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 874060205:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	— class O/S missing	803,435	$18,989,000	—	31 Mar 2017	13F
World Asset Management Inc	13F	Company	— class O/S missing	98,492	$2,311,000	—	31 Mar 2017	13F
QUADRANT CAPITAL GROUP LLC	13F	Company	— class O/S missing	5,126	$118,000	—	31 Mar 2017	13F
Hexavest Inc.	13F	Company	— class O/S missing	1,134	$27,000	—	31 Mar 2017	13F
GLENMEDE TRUST CO NA	13F	Company	— class O/S missing	944	$21,000	—	31 Mar 2017	13F
Geneos Wealth Management Inc.	13F	Company	— class O/S missing	364	$8,000	—	31 Mar 2017	13F
MassMutual Private Wealth & Trust, FSB	13F	Company	— class O/S missing	84	$1,985	—	31 Mar 2017	13F
First Horizon Advisors, Inc.	13F	Company	— class O/S missing	75	$1,000	—	31 Mar 2017	13F

Institutional Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q2 2017

As of 30 Jun 2017, TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,039,668 shares. The largest 8 holders included Parametric Portfolio Associates LLC, World Asset Management Inc, QUADRANT CAPITAL GROUP LLC, Hexavest Inc., GLENMEDE TRUST CO NA, Geneos Wealth Management Inc., MASSMUTUAL TRUST CO FSB/ADV, and FTB Advisors, Inc.. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

Q2 2017 holders

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.